Patent Number: 6,294,662

Title: Nucleic acids encoding an endometrial bleeding associated factor (ebaf)

Abstract: A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.

Inventors: Tabibzadeh; Siamak (Searingtown, NY)

Assignee: University of South Florida

International Classification: C12Q 1/68 (20060101); G01N 33/574 (20060101); C07H 021/04 (); C12Q 001/68 ()

Expiration Date: 09/25/2018